ArticleRheumatology (Oxford, England)2022

Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.

Walter P Maksymowych et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.